Efficacy and Safety of Low‐Dose Ashwagandha Supplementation on Exercise Endurance: A Randomized, Placebo‐Controlled, Double‐Blind, Clinical Trial
Phytotherapy Research · 2026-08 · 40 (8) · 4978-4987
DOI: 10.1002/ptr.70178 ↗At a glance
Randomisierte kontrollierte Studie in Phytotherapy Research, published online on 2026-03-17. Written by Himanshu Prajapati and 4 co-authors. Institution: Prajna Health Care, Ahmedabad, India. Major MEDLINE topics: Withania, Dietary Supplements, Plant Extracts, Exercise. Cited 1 times so far (Crossref); 24 references. The full text is freely available in PubMed Central. Funded by: Natural Remedies Pvt. Ltd..
Abstract (original language)
Ashwagandha ( Withania somnifera ) is a well‐known adaptogen with established roles in stress modulation and physical performance enhancement traditionally. Low dose Ashwagandha (LDA/Ashwa.30) is a bioactive‐optimized root‐only extract standardized to withanolides (> 15% w/w) and an ATP‐active fraction (> 15% w/w). This study investigated the efficacy and safety of LDA supplementation on cardiorespiratory fitness and exercise‐induced fatigue in healthy individuals. In this eight‐week, randomized, double‐blind, placebo‐controlled study, healthy adults received either LDA (30 mg/day) or placebo. VO 2 max was assessed as primary endpoint using an indirect method via the Modified Bruce Protocol Treadmill Test (MBPTT). Secondary endpoints included lactic acid, creatine phosphokinase (CPK), Rating of Perceived Exertion (RPE), fatigue scores (VAS), and safety biomarkers. LDA significantly improved VO 2 max and maximal heart rate compared to the placebo. Participants in the treatment group showed lower lactic acid levels at exercise, indicating prolonged aerobic metabolism. CPK levels were significantly reduced, suggesting mitigation of muscle energy stress. Borg RPE and fatigue scores improved in the LDA group. LDA was well tolerated, with no treatment‐related adverse events. Hematological, hepatic, renal, metabolic, and vital sign parameters remained within normal clinical ranges following intake of LDA. LDA supplementation for 8 weeks significantly enhanced cardiorespiratory fitness, delayed fatigue onset, and was safe for use in healthy adults. These findings support its potential as a safe and effective low‐dose aid for endurance enhancement and overall exercise performance.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Prajna Health Care, Ahmedabad, India.
- Ethicare Clinical Trial Services (OPC) Pvt. Ltd., Ahmedabad, India.
Funding
- Natural Remedies Pvt. Ltd.
Cite
APA
Prajapati, H., Satia, M., Shah, D., Basera, I., & Shah, T. (2026). Efficacy and Safety of Low‐Dose Ashwagandha Supplementation on Exercise Endurance: A Randomized, Placebo‐Controlled, Double‐Blind, Clinical Trial. Phytotherapy Research, 40(8), 4978-4987. https://doi.org/10.1002/ptr.70178
Vancouver
Prajapati H, Satia M, Shah D, Basera I, Shah T. Efficacy and Safety of Low‐Dose Ashwagandha Supplementation on Exercise Endurance: A Randomized, Placebo‐Controlled, Double‐Blind, Clinical Trial. Phytotherapy Research. 2026;40(8):4978-4987. doi:10.1002/ptr.70178
BibTeX
@article{Prajapati2026,
author = {Prajapati, Himanshu and Satia, Milan and Shah, Dhara and Basera, Ishita and Shah, Tanvi},
title = {Efficacy and Safety of Low‐Dose Ashwagandha Supplementation on Exercise Endurance: A Randomized, Placebo‐Controlled, Double‐Blind, Clinical Trial},
journal = {Phytotherapy Research},
year = {2026},
volume = {40},
number = {8},
pages = {4978--4987},
doi = {10.1002/ptr.70178}
}
EUVIMED